Paul F. McKenzie, PhD
CSL Behring
Chief Operating Officer
Paul McKenzie was appointed Chief Operating Officer of CSL Limited in June 2019 and leads the company’s global end-to-end operations organization and its accompanying strategy.
This role includes responsibility for CSL Plasma, manufacturing, quality, engineering, environment, health and safety, business technology, supply chain, procurement, business services and enterprise excellence. <br><br>
Paul is an accomplished global leader with diverse biotechnology experience across the industry. Prior to joining CSL, he served as Executive Vice President of Pharmaceutical Operations & Technology at Biogen, where he was responsible for asset management, technical development, global manufacturing, supply chain operations, quality and engineering. <br><br>
With more than 25 years of experience, Paul also held various senior roles in R&D and manufacturing for Johnson & Johnson, Bristol-Myers Squibb and Merck. Paul was recently elected to the National Academy of Engineering. He has served on numerous professional and academic boards, most recently the Board of Trustees for the Illinois Institute of Technology and the Society for Biological Engineering. Paul holds a B.S. in Chemical Engineering from the University of Pennsylvania and a Ph.D. in Chemical Engineering from Carnegie Mellon University.
This role includes responsibility for CSL Plasma, manufacturing, quality, engineering, environment, health and safety, business technology, supply chain, procurement, business services and enterprise excellence. <br><br>
Paul is an accomplished global leader with diverse biotechnology experience across the industry. Prior to joining CSL, he served as Executive Vice President of Pharmaceutical Operations & Technology at Biogen, where he was responsible for asset management, technical development, global manufacturing, supply chain operations, quality and engineering. <br><br>
With more than 25 years of experience, Paul also held various senior roles in R&D and manufacturing for Johnson & Johnson, Bristol-Myers Squibb and Merck. Paul was recently elected to the National Academy of Engineering. He has served on numerous professional and academic boards, most recently the Board of Trustees for the Illinois Institute of Technology and the Society for Biological Engineering. Paul holds a B.S. in Chemical Engineering from the University of Pennsylvania and a Ph.D. in Chemical Engineering from Carnegie Mellon University.